U.S. Industrials Stock News

NasdaqGS:BKR
NasdaqGS:BKREnergy Services

Should Baker Hughes’ AI Data Center Power Deal Expansion Require Action From Baker Hughes (BKR) Investors?

In February 2026, Baker Hughes announced it would supply 25 BRUSH Power Generation electric generators, Automatic Voltage Regulators and cubicles to Boom Supersonic, expanding a prior 2025 agreement to support 1.3 GW of onsite power capacity for AI-focused data centers through deliveries scheduled from mid-2026 to 2028. This contract underscores Baker Hughes’ push into higher-value Industrial & Energy Technology solutions, tying its generator portfolio directly to the fast-growing AI data...
NasdaqGM:ARRY
NasdaqGM:ARRYElectrical

Array Technologies (ARRY) Q4 Loss Of US$161 Million Renews Doubts Around Profitability Narratives

Array Technologies (ARRY) has just wrapped up FY 2025 with Q4 revenue of US$226.0 million and a basic EPS loss of US$1.06, alongside trailing twelve month revenue of about US$1.3 billion and a TTM basic EPS loss of US$0.73. The company has seen quarterly revenue range from US$231.4 million in Q3 2024 to US$393.5 million in Q3 2025, while basic EPS has swung between a loss of US$1.02 in Q3 2024 and a profit of US$0.19 in Q2 2025. This sets up a story where investors are watching how...
NasdaqGS:FAST
NasdaqGS:FASTTrade Distributors

Fastenal CEO Pay Jump, Insider Buying And Contracts Versus Rich Valuation

Fastenal (NasdaqGS:FAST) reported a 59% year over year increase in CEO Daniel L. Florness's compensation in a new SEC filing. Multiple insiders have purchased Fastenal stock over the past six months. The company has been awarded nearly $8 million in government contracts over the last year. Fastenal, trading at around $45.68 per share, has seen its stock return 13.0% year to date and 25.9% over the past year, with longer term gains of 85.9% over three years and 133.3% over five years. In...
NasdaqGM:NTLA
NasdaqGM:NTLABiotechs

Intellia Therapeutics Q4 Loss Of US$0.83 EPS Tests Long Term Bullish Narratives

Intellia Therapeutics (NTLA) closed FY 2025 with Q4 revenue of US$23.0 million and a basic EPS loss of US$0.83, as the company continued to invest heavily in its gene editing pipeline. Over the last six quarters, revenue has moved from US$9.1 million in Q3 2024 to US$23.0 million in Q4 2025, while quarterly basic EPS losses have ranged between US$0.83 and US$1.34. This has left margins firmly in loss-making territory even as the top line scaled up. See our full analysis for Intellia...
NYSE:HNGE
NYSE:HNGEHealthcare

Hinge Health Insider Sales Prompt Fresh Look At Growth Story

Hinge Health (NYSE:HNGE) President James Pursley recently sold company shares, extending a pattern of insider transactions over the past year. The latest sale adds to ongoing insider activity that investors may track alongside the company’s trading performance and business developments. Hinge Health, trading at $43.67 at the last close, has seen its share price move 4.2% over the past week and 8.1% over the past month. Year to date, the stock shows a 4.1% decline, which gives investors some...
NasdaqGS:VC
NasdaqGS:VCAuto Components

Visteon (VC) Is Up 5.1% After Dividend Hike And Buybacks Amid Softer 2025 Earnings

In February 2026, Visteon Corporation reported fourth-quarter and full-year 2025 results showing softer net income and earnings per share alongside slightly lower annual sales of US$3.77 billion, while its Board raised the quarterly dividend to US$0.375 per share payable on March 16, 2026, and confirmed 2026 sales guidance of US$3.63 billion to US$3.83 billion. At the same time, Visteon completed a US$225.93 million share repurchase program that retired about 7.17% of its shares, signaling a...
OTCPK:FMBL
OTCPK:FMBLBanks

Is Farmers & Merchants Bank of Long Beach (OTCPK:FMBL) Trading Too Far Above Its Fundamentals?

If you are wondering whether Farmers & Merchants Bank of Long Beach is priced attractively at around US$8,435 per share, you are not alone. This article is built to help you frame that question clearly. The stock has been relatively steady in the short term, with a 0.2% 7 day decline and returns of 1.0% over 30 days, 1.9% year to date and 50.9% over the last year, plus 29.0% over 3 years and 24.3% over 5 years. Recent coverage of Farmers & Merchants Bank of Long Beach has focused on its...
NasdaqGS:RELY
NasdaqGS:RELYDiversified Financial

The Bull Case For Remitly Global (RELY) Could Change Following Profitability, 2026 Outlook And New AI-Focused CEO

Remitly Global has reported past fourth-quarter 2025 revenue of US$442.18 million and full-year revenue of US$1.64 billion, swung to profitability, issued positive 2026 guidance, and announced Sebastian J. Gunningham as its new CEO while co-founder Matt Oppenheimer remains Chairman. The combination of a return to net income, guidance for continued revenue growth, and leadership bringing deep payments and AI experience is reshaping how investors assess Remitly’s long-term role in digital...
NYSE:SYK
NYSE:SYKMedical Equipment

Is It Too Late To Consider Stryker (SYK) After Recent Share Price Strength?

If you are wondering whether Stryker's share price around US$386 still offers value, you are not alone; many investors are trying to work out what a fair price looks like today. Over shorter periods, the stock has seen returns of 3.6% over the last 7 days, 8.9% over the last 30 days and 10.9% year to date, while the 1 year return sits at 0.2% and the 3 and 5 year returns are 51.6% and 72.4% respectively. Recent news coverage around Stryker has mainly centered on its position as a large...
NYSE:ALSN
NYSE:ALSNMachinery

Allison Transmission Raises Dividend As Acquisition Reshapes Cash Return Potential

Allison Transmission Holdings (NYSE:ALSN) has approved a 7% increase to its quarterly dividend. The dividend change follows the completion of the Off Highway Drive & Motion Systems acquisition from Dana Incorporated. The acquisition expands Allison's product portfolio and global presence in drivetrain and propulsion systems. Allison Transmission Holdings, known for its fully automatic transmissions and propulsion solutions, is leaning further into its core strengths as it integrates the Off...
NasdaqGS:SNPS
NasdaqGS:SNPSSoftware

Synopsys (SNPS) Margin Compression In Q1 2026 Challenges High Growth Narratives

Synopsys (SNPS) has kicked off Q1 2026 with total revenue of US$2.4b and basic EPS of US$0.34, setting the stage against a trailing twelve month picture that includes US$8.0b in revenue and basic EPS of US$6.40. Over recent quarters, the company has reported revenue of US$1.46b in Q1 2025, US$1.60b in Q2, US$1.74b in Q3 and US$2.25b in Q4, while quarterly basic EPS over that period ranged from US$1.91 to US$2.42. With trailing net profit margins now at 13.8% and influenced by a large one off...
NYSE:WT
NYSE:WTCapital Markets

WisdomTree’s Tokenized Fund Approval Tests Growth Promise Against Rich Valuation

WisdomTree (NYSE:WT) received SEC approval to offer intraday trading and instant settlement for tokenized shares of its Treasury Money Market Digital Fund. The approval allows 24/7 trading of these tokenized money market fund shares in the U.S. This marks a first of its kind use of blockchain infrastructure for a registered U.S. mutual fund with continuous trading and immediate settlement. WisdomTree, known for its exchange traded products and digital asset initiatives, is moving deeper...
NasdaqGM:ACMR
NasdaqGM:ACMRSemiconductor

ACM Research (ACMR) Margin Compression Challenges Bullish Growth Narratives After FY 2025 Results

ACM Research FY 2025 Earnings Snapshot ACM Research (ACMR) has wrapped up FY 2025 with fourth quarter revenue of US$244.4 million and basic EPS of US$0.12, alongside trailing twelve month revenue of US$901.3 million and EPS of US$1.47. Over recent periods the company has seen quarterly revenue move from US$223.5 million and EPS of US$0.49 in Q4 2024 to a peak of US$269.2 million and EPS of US$0.56 in Q3 2025 before landing at current levels. This puts the spotlight squarely on how efficiently...
NasdaqGS:HST
NasdaqGS:HSTHotel and Resort REITs

Host Hotels And Resorts HST Q4 FFO Strength Tests Bearish Earnings Decline Narrative

Host Hotels & Resorts (HST) has wrapped up FY 2025 with fourth quarter total revenue of US$1.6 billion and basic EPS of US$0.20, alongside funds from operations of US$340 million that remain the key gauge for this REIT. Over recent quarters, the company has seen revenue move from US$1.42 billion in Q4 2024 to US$1.60 billion in Q4 2025, while basic EPS shifted from US$0.15 to US$0.20. This gives investors a clearer view of how the top line and per share results are tracking into the latest...
NasdaqGM:AAOI
NasdaqGM:AAOICommunications

Applied Optoelectronics Ramps Up For AI Demand As Dilution Questions Grow

Applied Optoelectronics (NasdaqGM:AAOI) reports record fourth quarter and full year revenue driven by demand in data center and CATV segments. The company highlights rapid growth in orders for next generation 800G transceivers linked to hyperscale and AI data center investments. AAOI plans a major manufacturing expansion, including a new facility in Texas and a plan to triple laser manufacturing capacity. The company launches a US$250 million at the market stock offering to support growth...
NasdaqGS:TWST
NasdaqGS:TWSTBiotechs

Is Twist Bioscience (TWST) Using Invenra Deal To Quietly Redefine Its Biologics Platform Strategy?

In February 2026, Twist Bioscience Corporation announced it had entered a licensing agreement with Invenra Inc., becoming co-exclusive provider of Invenra’s B-Body bispecific antibody platform and extending its antibody discovery services, in exchange for US$5,000,000 in cash, US$15,000,000 in common stock, and an additional US$13,800,000 stock-funded preferred stake of about 6% in Invenra. By securing rights to Invenra’s bispecific antibody technology and all associated discovery and...
NYSE:BHC
NYSE:BHCPharmaceuticals

Is Bausch Health (BHC) Pricing Reflect Its Sharp Multi‑Year Share Price Declines?

If you are looking at Bausch Health Companies and wondering whether the current share price reflects its underlying value, you are not alone. The stock last closed at US$6.04, with returns of 1.9% over the past week and 5.6% over the past month, against year to date and 1 year returns of 16.2% and 21.0% declines, and a 34.7% and 81.1% decline over 3 and 5 years respectively. These moves have kept valuation in focus for many investors, especially as headlines continue to frame Bausch Health...
NYSE:TFX
NYSE:TFXMedical Equipment

Teleflex (TFX) Discontinued Losses Challenge Bullish Earnings Growth Narrative

Teleflex (TFX) has just posted its FY 2025 fourth quarter numbers, with revenue of US$569 million and a basic EPS loss of US$0.08, while trailing twelve month revenue sits at US$2.0 billion and EPS at US$1.31. Over recent quarters, revenue has ranged from US$569 million to US$913 million, with quarterly basic EPS swinging between a loss of US$9.24 and a profit of US$2.77. This underscores how headline earnings have been heavily affected by discontinued operations and one off items. With...
NYSE:WAB
NYSE:WABMachinery

Is It Too Late To Consider Wabtec (WAB) After Its Strong Multi‑Year Rally?

If you are wondering whether Westinghouse Air Brake Technologies at around US$263.41 is priced for perfection or still offers value, this article is designed to help you frame that question clearly. The stock has recent returns of 0.6% over 7 days, 13.7% over 30 days, 21.8% year to date, 46.1% over 1 year and 273.9% over 5 years, which naturally raises questions about growth potential and how risk is being priced in now. Recent news coverage around Westinghouse Air Brake Technologies has...
NYSE:TAL
NYSE:TALConsumer Services

Is TAL Education Group (TAL) Mispriced After Years Of Share Price Weakness?

If you are wondering whether TAL Education Group's share price still reflects its true value, you are not alone, especially given how different its past performance looks over various time frames. The stock last closed at US$10.89, with returns of 0.2% decline over 7 days, 2.3% over 30 days, a 5.2% decline year to date, a 17.9% decline over 1 year and 37.8% over 3 years, compared with a much larger 85.5% decline over 5 years. These mixed returns sit against a backdrop of ongoing regulatory...
NYSE:FLS
NYSE:FLSMachinery

What Flowserve (FLS)'s Dividend Hike and Analyst Upgrades Mean For Shareholders

Earlier this month, Flowserve Corporation’s Board of Directors approved a quarterly cash dividend of US$0.22 per share, a 5% increase on the prior payout, payable on April 10, 2026 to shareholders of record as of March 27, 2026. This higher dividend, alongside recent upward analyst earnings revisions and recognition for strong momentum characteristics, highlights growing confidence in Flowserve’s operational and market positioning. Next, we’ll examine how the recent dividend increase and...
NYSE:MKC
NYSE:MKCFood

Is McCormick’s (MKC) Reformulation Push Quietly Reshaping Its Long‑Term Competitive Moat?

Earlier this month, McCormick & Company filed an omnibus shelf registration covering common stock, non-voting common stock, and debt securities, while its CEO reported a surge in customer requests to reformulate products by removing artificial ingredients, cutting salt, and adding new flavor concepts. By moving earlier into customers’ product development cycles and focusing reformulation on emerging consumer preferences, McCormick is positioning its flavor expertise as a core ingredient in...
NYSE:HLF
NYSE:HLFPersonal Products

Herbalife Debt Refinance Puts Financial Flexibility And Growth Narrative In Focus

Herbalife (NYSE:HLF) has launched a major refinancing of its senior secured debt, targeting a large portion of its existing obligations. The company is pairing this move with an update on product driven performance, highlighting strong momentum in markets such as India. Management is also emphasizing continued investment in its distributor network alongside ongoing product development. Herbalife comes into this refinancing with its shares at $19.28 and a mixed return profile. The stock is...
NasdaqGM:PAYO
NasdaqGM:PAYODiversified Financial

Payoneer Global PAYO Margin Drop To 7% Tests Bullish Earnings Growth Narrative

Payoneer Global FY 2025 Earnings Snapshot Payoneer Global (PAYO) has capped FY 2025 with fourth quarter total revenue of US$274.7 million and basic EPS of US$0.05, while trailing twelve month revenue sits at about US$1.1 billion alongside basic EPS of roughly US$0.20. Over recent periods, the company has seen quarterly revenue move from US$261.7 million in Q4 2024 to US$274.7 million in Q4 2025, with basic EPS shifting between US$0.05 and US$0.06 over the FY 2025 quarters. With trailing net...